Exchange Grants Kolon TissueGene a One-Year Improvement Period

[Asia Economy Reporter Eunmo Koo] The Korea Exchange KOSDAQ Market Committee announced on the 17th through a public notice that it has decided to grant Kolon TissueGene a one-year improvement period. The end date of the improvement period is December 17 of next year, and Kolon TissueGene must submit a report on the implementation of the improvement plan and an expert's verification of the results of the improvement plan within 7 business days after the end of the improvement period. The Exchange plans to hold a KOSDAQ Market Committee meeting within 15 business days from the submission date of the documents to reconsider and decide on the delisting status.